Displaying 1 - 20 of 1530
FTC Submits Comment Supporting Proposed USPTO Terminal Disclaimer Rule
FTC Releases Interim Staff Report on Prescription Drug Middlemen
Novant Health, Inc. and Community Health Systems, Inc., In the Matter of
Statement Regarding the Termination of Novant Health’s Acquisition of Hospitals from Community Health Systems
Legion Media LLC, et al., FTC v.
In July 2024, a U.S. district court in central Florida unsealed a Federal Trade Commission complaint charging two related groups of defendants with defrauding consumers nationwide by enrolling them, without their knowledge, into continuity plans where they are shipped and charged repeatedly for personal care products that they did not agree to purchase.
The defendants allegedly deceived consumers with ads for “free” CBD and Keto-related personal care products, billing many for products they did not consent to purchase, signing many up for unwanted continuity plans, and debiting money from their bank accounts without prior authorization.
FTC Announces Final Eyeglass Rule Implementing Updates to Promote Competition and Expand Consumer Choice
16 CFR Part 456 Ophthalmic Practice Rule (Eyeglass Rule) - Final Rule - June 2024
FTC Submits Comment Supporting Proposed USPTO Rule
FTC Releases Fiscal Year 2023 Annual Report
Simple Health Plans LLC
On Oct. 29, 2018, the Federal Trade Commission filed a complaint in federal court against Simple Health Plans LLC, Steven J. Dorfman, and five other entities, alleging that the defendants misled people to think they were buying comprehensive health insurance that would cover preexisting medical conditions, prescription drugs, primary and specialty care treatment, inpatient and emergency hospital care, surgical procedures, and medical and laboratory testing. On Nov. 1, 2019, the FTC filed an amended complaint adding Candida Girouard as an additional defendant.